ERBB4
Summary: This gene is a member of the Tyr protein kinase family and the epidermal growth factor receptor subfamily. It encodes a single-pass type I membrane protein with multiple cysteine rich domains, a transmembrane domain, a tyrosine kinase domain, a phosphotidylinositol-3 kinase binding site and a PDZ domain binding motif. The protein binds to and is activated by neuregulins and other factors and induces a variety of cellular responses including mitogenesis and differentiation. Multiple proteolytic events allow for the release of a cytoplasmic fragment and an extracellular fragment. Mutations in this gene have been associated with cancer. Alternatively spliced variants which encode different protein isoforms have been described; however, not all variants have been fully characterized. [provided by RefSeq, Jul 2008].
| Name | OMIM ID | Ensembl ID | HGNC ID | PHARMGKB ID | Map Location |
|---|---|---|---|---|---|
| erb-b2 receptor tyrosine kinase 4 | MIM:600543 | Ensembl:ENSG00000178568 | HGNC:HGNC:3432 | PA27847 | 2q34 |
GO terms in ERBB4
| Term Type | Evidence Type | GO Term ID | GO Des. |
|---|---|---|---|
| BP | TAS | GO:0000165 | MAPK cascade |
| BP | ISS | GO:0001755 | neural crest cell migration |
| BP | TAS | GO:0001934 | positive regulation of protein phosphorylation |
| BP | IEA | GO:0006351 | transcription, DNA-templated |
| BP | IDA | GO:0007165 | signal transduction |
| BP | IDA | GO:0007169 | transmembrane receptor protein tyrosine kinase signaling pathway |
| BP | IBA | GO:0007275 | multicellular organism development |
| BP | ISS | GO:0007399 | nervous system development |
| BP | ISS | GO:0007507 | heart development |
| BP | IMP | GO:0007595 | lactation |
| BP | TAS | GO:0008283 | cell proliferation |
| BP | IMP | GO:0008284 | positive regulation of cell proliferation |
| BP | IMP | GO:0008285 | negative regulation of cell proliferation |
| BP | ISS | GO:0009880 | embryonic pattern specification |
| BP | IBA | GO:0009968 | negative regulation of signal transduction |
| BP | IEA | GO:0014068 | positive regulation of phosphatidylinositol 3-kinase signaling |
| BP | IDA | GO:0016477 | cell migration |
| BP | IDA | GO:0018108 | peptidyl-tyrosine phosphorylation |
| BP | ISS | GO:0021551 | central nervous system morphogenesis |
| BP | ISS | GO:0021889 | olfactory bulb interneuron differentiation |
| BP | IBA | GO:0030154 | cell differentiation |
| BP | ISS | GO:0030334 | regulation of cell migration |
| BP | IBA | GO:0033674 | positive regulation of kinase activity |
| BP | IEA | GO:0038083 | peptidyl-tyrosine autophosphorylation |
| BP | TAS | GO:0038128 | ERBB2 signaling pathway |
| BP | IMP | GO:0042531 | positive regulation of tyrosine phosphorylation of STAT protein |
| BP | IEA | GO:0043065 | positive regulation of apoptotic process |
| BP | IBA | GO:0043066 | negative regulation of apoptotic process |
| BP | IEA | GO:0043066 | negative regulation of apoptotic process |
| BP | IBA | GO:0043410 | positive regulation of MAPK cascade |
| BP | IMP | GO:0043653 | mitochondrial fragmentation involved in apoptotic process |
| BP | IEA | GO:0045165 | cell fate commitment |
| BP | IMP | GO:0045893 | positive regulation of transcription, DNA-templated |
| BP | IMP | GO:0046427 | positive regulation of JAK-STAT cascade |
| BP | IDA | GO:0046777 | protein autophosphorylation |
| BP | IEA | GO:0046854 | phosphatidylinositol phosphorylation |
| BP | TAS | GO:0051897 | positive regulation of protein kinase B signaling |
| BP | ISS | GO:0060045 | positive regulation of cardiac muscle cell proliferation |
| BP | ISS | GO:0060644 | mammary gland epithelial cell differentiation |
| BP | ISS | GO:0060749 | mammary gland alveolus development |
| BP | ISS | GO:0061026 | cardiac muscle tissue regeneration |
| BP | IBA | GO:0070374 | positive regulation of ERK1 and ERK2 cascade |
| BP | IMP | GO:0070374 | positive regulation of ERK1 and ERK2 cascade |
| BP | IEA | GO:0071364 | cellular response to epidermal growth factor stimulus |
| BP | IEA | GO:2000010 | positive regulation of protein localization to cell surface |
| BP | TAS | GO:2000145 | regulation of cell motility |
| BP | IEA | GO:2001223 | negative regulation of neuron migration |
| CC | TAS | GO:0005576 | extracellular region |
| CC | IDA | GO:0005634 | nucleus |
| CC | TAS | GO:0005654 | nucleoplasm |
| CC | IBA | GO:0005737 | cytoplasm |
| CC | IDA | GO:0005739 | mitochondrion |
| CC | TAS | GO:0005759 | mitochondrial matrix |
| CC | TAS | GO:0005829 | cytosol |
| CC | TAS | GO:0005886 | plasma membrane |
| CC | IBA | GO:0005887 | integral component of plasma membrane |
| CC | IBA | GO:0009925 | basal plasma membrane |
| CC | IEA | GO:0016021 | integral component of membrane |
| CC | IDA | GO:0016323 | basolateral plasma membrane |
| CC | IBA | GO:0043235 | receptor complex |
| CC | IDA | GO:0043235 | receptor complex |
| MF | IBA | GO:0004709 | MAP kinase kinase kinase activity |
| MF | IBA | GO:0004713 | protein tyrosine kinase activity |
| MF | IDA | GO:0004713 | protein tyrosine kinase activity |
| MF | TAS | GO:0004713 | protein tyrosine kinase activity |
| MF | IBA | GO:0004714 | transmembrane receptor protein tyrosine kinase activity |
| MF | IDA | GO:0004714 | transmembrane receptor protein tyrosine kinase activity |
| MF | IBA | GO:0004888 | transmembrane signaling receptor activity |
| MF | TAS | GO:0005088 | Ras guanyl-nucleotide exchange factor activity |
| MF | IBA | GO:0005154 | epidermal growth factor receptor binding |
| MF | IPI | GO:0005154 | epidermal growth factor receptor binding |
| MF | IPI | GO:0005515 | protein binding |
| MF | IEA | GO:0005524 | ATP binding |
| MF | IBA | GO:0031434 | mitogen-activated protein kinase kinase binding |
| MF | IPI | GO:0042803 | protein homodimerization activity |
| MF | IMP | GO:0044212 | transcription regulatory region DNA binding |
| MF | TAS | GO:0046934 | phosphatidylinositol-4,5-bisphosphate 3-kinase activity |
Gene expression in normal tissue: ERBB4
Gene-model tissue-cancer distribution: Bubble Plot
Gene-drug pathway distribution
Pathways in ERBB4
| Database | Pathway ID | Pathway Des. |
|---|---|---|
| reactome | R-HSA-1227986 | Signaling by ERBB2 |
| reactome | R-HSA-1227986 | Signaling by ERBB2 |
| reactome | R-HSA-1236394 | Signaling by ERBB4 |
| reactome | R-HSA-1236394 | Signaling by ERBB4 |
| reactome | R-HSA-1250196 | SHC1 events in ERBB2 signaling |
| reactome | R-HSA-1250196 | SHC1 events in ERBB2 signaling |
| reactome | R-HSA-1250342 | PI3K events in ERBB4 signaling |
| reactome | R-HSA-1250347 | SHC1 events in ERBB4 signaling |
| reactome | R-HSA-1251985 | Nuclear signaling by ERBB4 |
| reactome | R-HSA-1251985 | Nuclear signaling by ERBB4 |
| reactome | R-HSA-1253288 | Downregulation of ERBB4 signaling |
| reactome | R-HSA-1257604 | PIP3 activates AKT signaling |
| reactome | R-HSA-162582 | Signal Transduction |
| reactome | R-HSA-162582 | Signal Transduction |
| reactome | R-HSA-1643685 | Disease |
| reactome | R-HSA-1963640 | GRB2 events in ERBB2 signaling |
| reactome | R-HSA-1963642 | PI3K events in ERBB2 signaling |
| reactome | R-HSA-199418 | Negative regulation of the PI3K/AKT network |
| reactome | R-HSA-2219528 | PI3K/AKT Signaling in Cancer |
| reactome | R-HSA-2219530 | Constitutive Signaling by Aberrant PI3K in Cancer |
| reactome | R-HSA-5663202 | Diseases of signal transduction |
| reactome | R-HSA-5673001 | RAF/MAP kinase cascade |
| reactome | R-HSA-5683057 | MAPK family signaling cascades |
| reactome | R-HSA-5684996 | MAPK1/MAPK3 signaling |
| reactome | R-HSA-6785631 | ERBB2 Regulates Cell Motility |
| reactome | R-HSA-6811558 | PI5P, PP2A and IER3 Regulate PI3K/AKT Signaling |
| reactome | R-HSA-8847993 | ERBB2 Activates PTK6 Signaling |
| reactome | R-HSA-8848021 | Signaling by PTK6 |
| reactome | R-HSA-8863795 | Downregulation of ERBB2 signaling |
| reactome | R-HSA-8939211 | ESR-mediated signaling |
| reactome | R-HSA-9006925 | Intracellular signaling by second messengers |
| reactome | R-HSA-9006927 | Signaling by Non-Receptor Tyrosine Kinases |
| reactome | R-HSA-9006931 | Signaling by Nuclear Receptors |
| reactome | R-HSA-9006934 | Signaling by Receptor Tyrosine Kinases |
| reactome | R-HSA-9006934 | Signaling by Receptor Tyrosine Kinases |
| reactome | R-HSA-9018519 | Estrogen-dependent gene expression |
| biocarta | erbb4pathway | g-secretase mediated erbb4 signaling pathway |
| biocarta | her2pathway | role of erbb2 in signal transduction and oncology |
| pharmgkb | PA162356267 | EGFR Inhibitor Pathway, Pharmacodynamics |
| pid | erbb4_pathway | ErbB4 signaling events |
| pid | erbb_network_pathway | ErbB receptor signaling network |
| netpath | Pathway_Prolactin | Prolactin |
| kegg | hsa04010 | MAPK signaling pathway - Homo sapiens (human) |
| kegg | hsa04012 | ErbB signaling pathway - Homo sapiens (human) |
| kegg | hsa04020 | Calcium signaling pathway - Homo sapiens (human) |
| kegg | hsa04151 | PI3K-Akt signaling pathway - Homo sapiens (human) |
| kegg | hsa05205 | Proteoglycans in cancer - Homo sapiens (human) |
| wikipathways | WP3297 | EV release from cardiac cells and their functional effects |
| wikipathways | WP3680 | Association Between Physico-Chemical Features and Toxicity Associated Pathways |
| wikipathways | WP673 | ErbB Signaling Pathway |
Gene-Drug: Aster Plot
| Drug ID | Drug Name | Model Num. |
|---|---|---|
| iGMDRD427 | ABT737 | 2 |
| iGMDRD546 | BMS-754807 | 4 |
| iGMDRD781 | Sirolimus | 2 |
| iGMDRD126 | Tipifarnib | 1 |
| iGMDRD433 | Lexibulin | 4 |
| iGMDRD151 | CHM-1 | 5 |
| iGMDRD599 | Salermide | 1 |
| iGMDRD772 | BRD4770 | 2 |
| iGMDRD425 | ERASTIN | 2 |
| iGMDRD579 | PF750 | 2 |
| iGMDRD297 | Austocystin D | 6 |
| iGMDRD394 | BX-795 | 3 |
| iGMDRD446 | LY 2183240 | 4 |
| iGMDRD201 | SKI II | 2 |
| iGMDRD193 | Fqi1 | 9 |
| iGMDRD782 | DC-45-A2 | 4 |
| iGMDRD318 | PAC-1 | 3 |
| iGMDRD885 | Compound 110 | 2 |
| iGMDRD801 | 2,4-dideoxy-DC-45-A2 | 2 |
| iGMDRD52 | Rotenone | 2 |
| iGMDRD187 | BRD9876 | 3 |
| iGMDRD870 | BRD63610 | 2 |
| iGMDRD270 | Ciclosporin | 1 |
| iGMDRD260 | FQI-2 | 3 |
| iGMDRD255 | SB225002 | 1 |
| iGMDRD64 | Parbendazole | 7 |
| iGMDRD451 | Serdemetan | 2 |
| iGMDRD100 | Zebularine | 2 |
| iGMDRD188 | Piperlongumine | 2 |
| iGMDRD133 | Lapatinib | 15 |
| iGMDRD74 | Idarubicin | 3 |
| iGMDRD888 | Compound 44 | 7 |
| iGMDRD506 | Fedratinib | 1 |
| iGMDRD562 | Navitoclax | 2 |
| iGMDRD780 | PP-30 | 2 |
| iGMDRD424 | Tamatinib | 4 |
| iGMDRD701 | NVP-AUY922 | 2 |
| iGMDRD84 | Lovastatin acid | 2 |
| iGMDRD307 | Manumycin A | 2 |
| iGMDRD1020 | Trastuzumab | 2 |
| iGMDRD901 | ELCPK | 5 |
| iGMDRD211 | (1S,3R)-RSL3 | 2 |
| iGMDRD123 | Isoevodiamine | 6 |
| iGMDRD154 | NSC23766 | 4 |
| iGMDRD351 | GW843682X | 4 |
| iGMDRD698 | Neratinib | 3 |
| iGMDRD237 | ABT-751 | 2 |
| iGMDRD705 | Nakiterpiosin | 2 |
| iGMDRD103 | SN-38 | 2 |
| iGMDRD121 | GMX1778 | 3 |
| iGMDRD137 | Indisulam | 2 |
| iGMDRD158 | NSC141540 | 7 |
| iGMDRD278 | TTNPB | 2 |
| iGMDRD505 | Pevonedistat | 1 |
| iGMDRD300 | Tozasertib | 2 |
| iGMDRD246 | NPC26 | 3 |
| iGMDRD322 | FK 866 | 4 |
| iGMDRD414 | MST-312 | 1 |
| iGMDRD286 | Nsc 632839 | 2 |
| iGMDRD367 | Ro 28-1675 | 3 |
| iGMDRD329 | Merck60 | 2 |
Gene in drug-gene network: Network Plot

Gene-drug targets distribution
Gene Structure: PDB
Models in ERBB4

